Share Price and Basic Stock Data
Last Updated: January 2, 2026, 5:49 pm
| PEG Ratio | 1.77 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Grauer & Weil (India) Ltd operates in the specialty chemicals sector, with a current market capitalization of ₹3,700 Cr and a stock price of ₹81.6. The company has demonstrated robust revenue growth, with sales reported at ₹981 Cr for FY 2023, an increase from ₹768 Cr in FY 2022, thereby reflecting a year-on-year growth of 27.7%. For FY 2024, sales further rose to ₹1,068 Cr, and the trailing twelve months (TTM) sales stood at ₹1,159 Cr, indicating a consistent upward trajectory. Quarterly sales figures show fluctuations, with the highest quarterly sales of ₹333 Cr recorded in March 2025, while the lowest was ₹200 Cr in June 2023. The company’s operational efficiency is highlighted by a net profit of ₹151 Cr, translating into a net profit margin of 13.86% for FY 2025. Overall, Grauer & Weil’s revenue trends underscore its ability to capitalize on market opportunities within the specialty chemicals industry.
Profitability and Efficiency Metrics
Grauer & Weil reported a healthy operating profit margin (OPM) of 15% for FY 2025, which, while lower than the previous fiscal year’s OPM of 17%, remains competitive within the sector. The company’s net profit for the latest fiscal year stood at ₹157 Cr, with an earnings per share (EPS) of ₹3.47, indicating solid profitability. The return on equity (ROE) was recorded at 17.6%, while the return on capital employed (ROCE) stood at 23.3%, both figures suggesting efficient management of equity and capital. The interest coverage ratio (ICR) is exceptionally high at 85.67x, indicating a strong ability to meet interest obligations. However, the company experienced volatility in quarterly profits, with net profits peaking at ₹51 Cr in June 2024 and dipping to ₹22 Cr in March 2023. Such fluctuations may point to external market pressures or operational challenges, but overall profitability metrics remain robust.
Balance Sheet Strength and Financial Ratios
Grauer & Weil’s balance sheet exhibits strength, with total assets recorded at ₹1,286 Cr and minimal borrowings of only ₹12 Cr as of FY 2025. This results in a debt-to-equity ratio of 0.01, indicating a very low reliance on debt financing, which is favorable for financial stability. The company’s reserves stood at ₹952 Cr, reflecting a solid buffer for future investments and operational needs. The current ratio is reported at 3.15, suggesting strong liquidity, while the quick ratio of 2.63 indicates the company’s ability to meet short-term obligations without relying on inventory sales. The price-to-book value (P/BV) ratio is at 3.96x, which is relatively high compared to sector norms, indicating that the market may be pricing the stock at a premium. Overall, Grauer & Weil’s financial ratios portray a company that is both stable and well-positioned for growth.
Shareholding Pattern and Investor Confidence
The shareholding pattern of Grauer & Weil indicates significant promoter confidence, with promoters holding 69.03% of the company as of March 2025. This substantial stake suggests a strong alignment of interests between management and shareholders. However, foreign institutional investors (FIIs) represent only 0.68% of the shareholding, which may reflect limited interest from international investors. Domestic institutional investors (DIIs) hold a mere 0.03%, indicating a potential area for growth in institutional interest. The public shareholding stands at 30.26%, and the number of shareholders has seen fluctuations, from 42,218 in December 2022 to 55,578 by September 2025, reflecting growing retail investor interest. This increase in shareholder base could enhance liquidity and market visibility, fostering greater investor confidence in the company’s future prospects.
Outlook, Risks, and Final Insight
Looking ahead, Grauer & Weil is well-positioned to leverage its strengths in the specialty chemicals market, supported by solid financial metrics and a strong balance sheet. However, the company faces risks such as market volatility, fluctuations in raw material costs, and competition within the chemicals sector. Additionally, the low foreign institutional investor participation may limit stock appreciation potential. The company’s ability to maintain profitability amidst these challenges will be crucial. If Grauer & Weil can navigate these risks effectively, it could see continued growth and enhanced shareholder value. Conversely, any significant downturns in the market or operational challenges could impede its performance. Overall, Grauer & Weil’s fundamentals suggest a resilient business model, but vigilance regarding external market conditions will be essential for sustained success.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| HP Adhesives Ltd | 392 Cr. | 42.7 | 80.8/40.0 | 24.4 | 20.5 | 0.94 % | 13.6 % | 9.82 % | 2.00 |
| Haryana Leather Chemicals Ltd | 31.2 Cr. | 63.5 | 88.8/56.0 | 14.9 | 89.6 | 1.57 % | 8.02 % | 5.45 % | 10.0 |
| Hardcastle & Waud Mfg Co Ltd | 49.4 Cr. | 726 | 932/600 | 22.8 | 697 | 0.00 % | 6.31 % | 2.91 % | 10.0 |
| Grauer & Weil (India) Ltd | 3,700 Cr. | 81.6 | 111/68.2 | 24.5 | 22.0 | 0.61 % | 23.3 % | 17.6 % | 1.00 |
| DMCC Speciality Chemicals Ltd | 637 Cr. | 256 | 393/230 | 22.9 | 93.8 | 0.98 % | 14.1 % | 9.97 % | 10.0 |
| Industry Average | 12,937.80 Cr | 718.94 | 67.19 | 183.02 | 0.43% | 12.99% | 25.41% | 6.41 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 205 | 251 | 327 | 200 | 250 | 285 | 333 | 264 | 255 | 275 | 340 | 253 | 291 |
| Expenses | 166 | 204 | 297 | 152 | 202 | 230 | 294 | 200 | 212 | 222 | 311 | 201 | 248 |
| Operating Profit | 39 | 47 | 30 | 48 | 49 | 55 | 39 | 64 | 43 | 52 | 30 | 53 | 43 |
| OPM % | 19% | 19% | 9% | 24% | 20% | 19% | 12% | 24% | 17% | 19% | 9% | 21% | 15% |
| Other Income | 4 | 5 | 4 | 6 | 7 | 9 | 8 | 8 | 14 | 12 | 12 | 13 | 11 |
| Interest | -0 | 1 | 1 | 0 | 0 | 0 | 3 | 0 | 0 | 1 | 2 | 1 | 0 |
| Depreciation | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 6 | 6 | 6 | 6 | 6 |
| Profit before tax | 38 | 47 | 29 | 48 | 51 | 58 | 39 | 67 | 51 | 58 | 34 | 58 | 48 |
| Tax % | 26% | 26% | 25% | 23% | 26% | 26% | 26% | 24% | 26% | 26% | 25% | 25% | 20% |
| Net Profit | 28 | 34 | 22 | 37 | 37 | 43 | 29 | 51 | 38 | 43 | 26 | 44 | 39 |
| EPS in Rs | 0.62 | 0.76 | 0.48 | 0.81 | 0.83 | 0.94 | 0.64 | 1.12 | 0.83 | 0.95 | 0.57 | 0.96 | 0.85 |
Last Updated: December 26, 2025, 5:16 pm
Below is a detailed analysis of the quarterly data for Grauer & Weil (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 291.00 Cr.. The value appears strong and on an upward trend. It has increased from 253.00 Cr. (Jun 2025) to 291.00 Cr., marking an increase of 38.00 Cr..
- For Expenses, as of Sep 2025, the value is 248.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 201.00 Cr. (Jun 2025) to 248.00 Cr., marking an increase of 47.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 43.00 Cr.. The value appears to be declining and may need further review. It has decreased from 53.00 Cr. (Jun 2025) to 43.00 Cr., marking a decrease of 10.00 Cr..
- For OPM %, as of Sep 2025, the value is 15.00%. The value appears to be declining and may need further review. It has decreased from 21.00% (Jun 2025) to 15.00%, marking a decrease of 6.00%.
- For Other Income, as of Sep 2025, the value is 11.00 Cr.. The value appears to be declining and may need further review. It has decreased from 13.00 Cr. (Jun 2025) to 11.00 Cr., marking a decrease of 2.00 Cr..
- For Interest, as of Sep 2025, the value is 0.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 1.00 Cr. (Jun 2025) to 0.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 6.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 6.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 48.00 Cr.. The value appears to be declining and may need further review. It has decreased from 58.00 Cr. (Jun 2025) to 48.00 Cr., marking a decrease of 10.00 Cr..
- For Tax %, as of Sep 2025, the value is 20.00%. The value appears to be improving (decreasing) as expected. It has decreased from 25.00% (Jun 2025) to 20.00%, marking a decrease of 5.00%.
- For Net Profit, as of Sep 2025, the value is 39.00 Cr.. The value appears to be declining and may need further review. It has decreased from 44.00 Cr. (Jun 2025) to 39.00 Cr., marking a decrease of 5.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.85. The value appears to be declining and may need further review. It has decreased from 0.96 (Jun 2025) to 0.85, marking a decrease of 0.11.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 3:37 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 380 | 409 | 413 | 432 | 497 | 600 | 618 | 605 | 768 | 981 | 1,068 | 1,134 | 1,159 |
| Expenses | 319 | 333 | 335 | 346 | 400 | 494 | 521 | 505 | 655 | 825 | 877 | 944 | 982 |
| Operating Profit | 61 | 76 | 78 | 86 | 98 | 106 | 97 | 101 | 114 | 156 | 191 | 189 | 178 |
| OPM % | 16% | 19% | 19% | 20% | 20% | 18% | 16% | 17% | 15% | 16% | 18% | 17% | 15% |
| Other Income | 3 | 1 | 2 | 4 | 10 | 5 | 20 | 15 | 16 | 18 | 31 | 46 | 48 |
| Interest | 17 | 14 | 10 | 3 | 3 | 2 | 3 | 3 | 3 | 3 | 5 | 4 | 3 |
| Depreciation | 12 | 16 | 14 | 14 | 15 | 15 | 19 | 18 | 20 | 20 | 21 | 22 | 24 |
| Profit before tax | 35 | 46 | 56 | 73 | 91 | 94 | 95 | 94 | 107 | 152 | 196 | 210 | 199 |
| Tax % | 14% | 28% | 24% | 26% | 30% | 32% | 21% | 27% | 26% | 26% | 25% | 25% | |
| Net Profit | 30 | 33 | 42 | 54 | 64 | 64 | 76 | 69 | 79 | 113 | 146 | 157 | 151 |
| EPS in Rs | 0.67 | 0.74 | 0.93 | 1.20 | 1.41 | 1.41 | 1.67 | 1.52 | 1.74 | 2.49 | 3.23 | 3.47 | 3.33 |
| Dividend Payout % | 12% | 15% | 15% | 17% | 21% | 21% | 15% | 16% | 19% | 16% | 8% | 14% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 10.00% | 27.27% | 28.57% | 18.52% | 0.00% | 18.75% | -9.21% | 14.49% | 43.04% | 29.20% | 7.53% |
| Change in YoY Net Profit Growth (%) | 0.00% | 17.27% | 1.30% | -10.05% | -18.52% | 18.75% | -27.96% | 23.70% | 28.55% | -13.83% | -21.67% |
Grauer & Weil (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 11% |
| 5 Years: | 13% |
| 3 Years: | 14% |
| TTM: | -1% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 17% |
| 3 Years: | 26% |
| TTM: | -6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 28% |
| 5 Years: | 35% |
| 3 Years: | 40% |
| 1 Year: | -11% |
| Return on Equity | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 17% |
| 3 Years: | 18% |
| Last Year: | 18% |
Last Updated: September 5, 2025, 3:40 pm
Balance Sheet
Last Updated: December 4, 2025, 2:59 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 23 | 45 | 45 |
| Reserves | 171 | 194 | 228 | 278 | 331 | 379 | 422 | 491 | 560 | 657 | 783 | 894 | 952 |
| Borrowings | 97 | 68 | 27 | 20 | 7 | 21 | 23 | 22 | 25 | 24 | 27 | 12 | 12 |
| Other Liabilities | 133 | 125 | 119 | 133 | 146 | 159 | 174 | 214 | 217 | 251 | 292 | 334 | 319 |
| Total Liabilities | 423 | 410 | 397 | 454 | 507 | 581 | 642 | 750 | 824 | 954 | 1,124 | 1,286 | 1,328 |
| Fixed Assets | 225 | 216 | 210 | 212 | 206 | 231 | 241 | 238 | 247 | 244 | 243 | 254 | 269 |
| CWIP | 1 | 0 | 0 | 0 | 0 | 3 | 1 | 4 | 1 | 3 | 14 | 27 | 20 |
| Investments | 3 | 2 | 1 | 1 | 3 | 1 | 0 | 0 | 1 | 17 | 49 | 71 | 407 |
| Other Assets | 194 | 192 | 186 | 241 | 297 | 346 | 399 | 508 | 576 | 690 | 817 | 934 | 633 |
| Total Assets | 423 | 410 | 397 | 454 | 507 | 581 | 642 | 750 | 824 | 954 | 1,124 | 1,286 | 1,328 |
Below is a detailed analysis of the balance sheet data for Grauer & Weil (India) Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 45.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 45.00 Cr..
- For Reserves, as of Sep 2025, the value is 952.00 Cr.. The value appears strong and on an upward trend. It has increased from 894.00 Cr. (Mar 2025) to 952.00 Cr., marking an increase of 58.00 Cr..
- For Borrowings, as of Sep 2025, the value is 12.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2025) which recorded 12.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 319.00 Cr.. The value appears to be improving (decreasing). It has decreased from 334.00 Cr. (Mar 2025) to 319.00 Cr., marking a decrease of 15.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 1,328.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,286.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 42.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 269.00 Cr.. The value appears strong and on an upward trend. It has increased from 254.00 Cr. (Mar 2025) to 269.00 Cr., marking an increase of 15.00 Cr..
- For CWIP, as of Sep 2025, the value is 20.00 Cr.. The value appears to be declining and may need further review. It has decreased from 27.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 7.00 Cr..
- For Investments, as of Sep 2025, the value is 407.00 Cr.. The value appears strong and on an upward trend. It has increased from 71.00 Cr. (Mar 2025) to 407.00 Cr., marking an increase of 336.00 Cr..
- For Other Assets, as of Sep 2025, the value is 633.00 Cr.. The value appears to be declining and may need further review. It has decreased from 934.00 Cr. (Mar 2025) to 633.00 Cr., marking a decrease of 301.00 Cr..
- For Total Assets, as of Sep 2025, the value is 1,328.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,286.00 Cr. (Mar 2025) to 1,328.00 Cr., marking an increase of 42.00 Cr..
Notably, the Reserves (952.00 Cr.) exceed the Borrowings (12.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -36.00 | 8.00 | 51.00 | 66.00 | 91.00 | 85.00 | 74.00 | 79.00 | 89.00 | 132.00 | 164.00 | 177.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 89 | 80 | 70 | 63 | 65 | 68 | 67 | 77 | 62 | 68 | 63 | 64 |
| Inventory Days | 109 | 120 | 115 | 118 | 100 | 106 | 126 | 108 | 121 | 83 | 90 | 98 |
| Days Payable | 79 | 67 | 68 | 82 | 81 | 68 | 95 | 110 | 91 | 77 | 86 | 90 |
| Cash Conversion Cycle | 119 | 133 | 117 | 99 | 83 | 106 | 99 | 75 | 92 | 75 | 68 | 72 |
| Working Capital Days | 17 | 26 | 50 | 38 | 49 | 56 | 57 | 36 | 49 | 43 | 34 | 32 |
| ROCE % | 18% | 21% | 24% | 25% | 27% | 26% | 20% | 19% | 19% | 24% | 26% | 23% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| Diluted EPS (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| Cash EPS (Rs.) | 3.96 | 7.38 | 5.86 | 4.34 | 3.85 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 20.72 | 35.52 | 29.96 | 25.69 | 22.67 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 20.72 | 35.52 | 29.96 | 25.69 | 22.67 |
| Revenue From Operations / Share (Rs.) | 25.00 | 47.15 | 43.31 | 33.89 | 26.72 |
| PBDIT / Share (Rs.) | 5.18 | 9.77 | 7.69 | 5.58 | 5.07 |
| PBIT / Share (Rs.) | 4.68 | 8.84 | 6.82 | 4.71 | 4.26 |
| PBT / Share (Rs.) | 4.62 | 8.66 | 6.70 | 4.71 | 4.16 |
| Net Profit / Share (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| NP After MI And SOA / Share (Rs.) | 3.47 | 6.45 | 4.98 | 3.47 | 3.04 |
| PBDIT Margin (%) | 20.70 | 20.71 | 17.75 | 16.45 | 18.97 |
| PBIT Margin (%) | 18.73 | 18.74 | 15.74 | 13.90 | 15.93 |
| PBT Margin (%) | 18.48 | 18.35 | 15.47 | 13.89 | 15.57 |
| Net Profit Margin (%) | 13.86 | 13.68 | 11.50 | 10.24 | 11.37 |
| NP After MI And SOA Margin (%) | 13.86 | 13.68 | 11.50 | 10.25 | 11.35 |
| Return on Networth / Equity (%) | 16.73 | 18.16 | 16.62 | 13.52 | 13.38 |
| Return on Capital Employeed (%) | 21.47 | 23.24 | 21.11 | 16.88 | 16.97 |
| Return On Assets (%) | 12.22 | 12.99 | 11.83 | 9.55 | 9.17 |
| Total Debt / Equity (X) | 0.01 | 0.02 | 0.02 | 0.03 | 0.03 |
| Asset Turnover Ratio (%) | 0.94 | 1.03 | 1.10 | 0.97 | 0.86 |
| Current Ratio (X) | 3.15 | 3.16 | 2.87 | 2.89 | 2.75 |
| Quick Ratio (X) | 2.63 | 2.64 | 2.30 | 2.14 | 2.24 |
| Inventory Turnover Ratio (X) | 7.71 | 4.22 | 4.11 | 3.81 | 3.03 |
| Dividend Payout Ratio (NP) (%) | 14.42 | 22.47 | 13.04 | 14.38 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 12.62 | 19.63 | 11.09 | 11.51 | 0.00 |
| Earning Retention Ratio (%) | 85.58 | 77.53 | 86.96 | 85.62 | 0.00 |
| Cash Earning Retention Ratio (%) | 87.38 | 80.37 | 88.91 | 88.49 | 0.00 |
| Interest Coverage Ratio (X) | 85.67 | 53.77 | 93.63 | 50.36 | 53.33 |
| Interest Coverage Ratio (Post Tax) (X) | 58.37 | 36.51 | 62.04 | 31.37 | 32.99 |
| Enterprise Value (Cr.) | 3259.26 | 3602.56 | 1964.44 | 1088.88 | 653.83 |
| EV / Net Operating Revenue (X) | 2.87 | 3.37 | 2.00 | 1.42 | 1.08 |
| EV / EBITDA (X) | 13.88 | 16.27 | 11.27 | 8.61 | 5.69 |
| MarketCap / Net Operating Revenue (X) | 3.28 | 3.74 | 2.27 | 1.73 | 1.47 |
| Retention Ratios (%) | 85.57 | 77.52 | 86.95 | 85.61 | 0.00 |
| Price / BV (X) | 3.96 | 4.97 | 3.29 | 2.28 | 1.73 |
| Price / Net Operating Revenue (X) | 3.28 | 3.74 | 2.27 | 1.73 | 1.47 |
| EarningsYield | 0.04 | 0.03 | 0.05 | 0.05 | 0.07 |
After reviewing the key financial ratios for Grauer & Weil (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For Diluted EPS (Rs.), as of Mar 25, the value is 3.47. This value is below the healthy minimum of 5. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For Cash EPS (Rs.), as of Mar 25, the value is 3.96. This value is within the healthy range. It has decreased from 7.38 (Mar 24) to 3.96, marking a decrease of 3.42.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 20.72. It has decreased from 35.52 (Mar 24) to 20.72, marking a decrease of 14.80.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 25.00. It has decreased from 47.15 (Mar 24) to 25.00, marking a decrease of 22.15.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 5.18. This value is within the healthy range. It has decreased from 9.77 (Mar 24) to 5.18, marking a decrease of 4.59.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.68. This value is within the healthy range. It has decreased from 8.84 (Mar 24) to 4.68, marking a decrease of 4.16.
- For PBT / Share (Rs.), as of Mar 25, the value is 4.62. This value is within the healthy range. It has decreased from 8.66 (Mar 24) to 4.62, marking a decrease of 4.04.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 3.47. This value is within the healthy range. It has decreased from 6.45 (Mar 24) to 3.47, marking a decrease of 2.98.
- For PBDIT Margin (%), as of Mar 25, the value is 20.70. This value is within the healthy range. It has decreased from 20.71 (Mar 24) to 20.70, marking a decrease of 0.01.
- For PBIT Margin (%), as of Mar 25, the value is 18.73. This value is within the healthy range. It has decreased from 18.74 (Mar 24) to 18.73, marking a decrease of 0.01.
- For PBT Margin (%), as of Mar 25, the value is 18.48. This value is within the healthy range. It has increased from 18.35 (Mar 24) to 18.48, marking an increase of 0.13.
- For Net Profit Margin (%), as of Mar 25, the value is 13.86. This value exceeds the healthy maximum of 10. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 13.86. This value is within the healthy range. It has increased from 13.68 (Mar 24) to 13.86, marking an increase of 0.18.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.73. This value is within the healthy range. It has decreased from 18.16 (Mar 24) to 16.73, marking a decrease of 1.43.
- For Return on Capital Employeed (%), as of Mar 25, the value is 21.47. This value is within the healthy range. It has decreased from 23.24 (Mar 24) to 21.47, marking a decrease of 1.77.
- For Return On Assets (%), as of Mar 25, the value is 12.22. This value is within the healthy range. It has decreased from 12.99 (Mar 24) to 12.22, marking a decrease of 0.77.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.01. This value is within the healthy range. It has decreased from 0.02 (Mar 24) to 0.01, marking a decrease of 0.01.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.94. It has decreased from 1.03 (Mar 24) to 0.94, marking a decrease of 0.09.
- For Current Ratio (X), as of Mar 25, the value is 3.15. This value exceeds the healthy maximum of 3. It has decreased from 3.16 (Mar 24) to 3.15, marking a decrease of 0.01.
- For Quick Ratio (X), as of Mar 25, the value is 2.63. This value exceeds the healthy maximum of 2. It has decreased from 2.64 (Mar 24) to 2.63, marking a decrease of 0.01.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 7.71. This value is within the healthy range. It has increased from 4.22 (Mar 24) to 7.71, marking an increase of 3.49.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 14.42. This value is below the healthy minimum of 20. It has decreased from 22.47 (Mar 24) to 14.42, marking a decrease of 8.05.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 12.62. This value is below the healthy minimum of 20. It has decreased from 19.63 (Mar 24) to 12.62, marking a decrease of 7.01.
- For Earning Retention Ratio (%), as of Mar 25, the value is 85.58. This value exceeds the healthy maximum of 70. It has increased from 77.53 (Mar 24) to 85.58, marking an increase of 8.05.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 87.38. This value exceeds the healthy maximum of 70. It has increased from 80.37 (Mar 24) to 87.38, marking an increase of 7.01.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 85.67. This value is within the healthy range. It has increased from 53.77 (Mar 24) to 85.67, marking an increase of 31.90.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 58.37. This value is within the healthy range. It has increased from 36.51 (Mar 24) to 58.37, marking an increase of 21.86.
- For Enterprise Value (Cr.), as of Mar 25, the value is 3,259.26. It has decreased from 3,602.56 (Mar 24) to 3,259.26, marking a decrease of 343.30.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.87. This value is within the healthy range. It has decreased from 3.37 (Mar 24) to 2.87, marking a decrease of 0.50.
- For EV / EBITDA (X), as of Mar 25, the value is 13.88. This value is within the healthy range. It has decreased from 16.27 (Mar 24) to 13.88, marking a decrease of 2.39.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
- For Retention Ratios (%), as of Mar 25, the value is 85.57. This value exceeds the healthy maximum of 70. It has increased from 77.52 (Mar 24) to 85.57, marking an increase of 8.05.
- For Price / BV (X), as of Mar 25, the value is 3.96. This value exceeds the healthy maximum of 3. It has decreased from 4.97 (Mar 24) to 3.96, marking a decrease of 1.01.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 3.28. This value exceeds the healthy maximum of 3. It has decreased from 3.74 (Mar 24) to 3.28, marking a decrease of 0.46.
- For EarningsYield, as of Mar 25, the value is 0.04. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.04, marking an increase of 0.01.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Grauer & Weil (India) Ltd:
- Net Profit Margin: 13.86%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 21.47% (Industry Average ROCE: 12.99%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.73% (Industry Average ROE: 25.41%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 58.37
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.63
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.5 (Industry average Stock P/E: 67.19)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.01
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 13.86%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Chemicals - Speciality - Others | Growel Corporate, Mumbai Maharashtra 400101 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Umeshkumar More | Chairman |
| Mr. Nirajkumar More | Managing Director |
| Mr. Rohitkumar More | Whole Time Director |
| Mr. Yogesh Samat | Whole Time Director |
| Dr. Prerna Goradia | Independent Director |
| Mr. Ayush Agarwala | Independent Director |
| Mr. Ashok Kumar Kanodia | Independent Director |
| Mr. Anil Gadodia | Independent Director |
FAQ
What is the intrinsic value of Grauer & Weil (India) Ltd?
Grauer & Weil (India) Ltd's intrinsic value (as of 04 January 2026) is ₹76.35 which is 6.43% lower the current market price of ₹81.60, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹3,700 Cr. market cap, FY2025-2026 high/low of ₹111/68.2, reserves of ₹952 Cr, and liabilities of ₹1,328 Cr.
What is the Market Cap of Grauer & Weil (India) Ltd?
The Market Cap of Grauer & Weil (India) Ltd is 3,700 Cr..
What is the current Stock Price of Grauer & Weil (India) Ltd as on 04 January 2026?
The current stock price of Grauer & Weil (India) Ltd as on 04 January 2026 is ₹81.6.
What is the High / Low of Grauer & Weil (India) Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Grauer & Weil (India) Ltd stocks is ₹111/68.2.
What is the Stock P/E of Grauer & Weil (India) Ltd?
The Stock P/E of Grauer & Weil (India) Ltd is 24.5.
What is the Book Value of Grauer & Weil (India) Ltd?
The Book Value of Grauer & Weil (India) Ltd is 22.0.
What is the Dividend Yield of Grauer & Weil (India) Ltd?
The Dividend Yield of Grauer & Weil (India) Ltd is 0.61 %.
What is the ROCE of Grauer & Weil (India) Ltd?
The ROCE of Grauer & Weil (India) Ltd is 23.3 %.
What is the ROE of Grauer & Weil (India) Ltd?
The ROE of Grauer & Weil (India) Ltd is 17.6 %.
What is the Face Value of Grauer & Weil (India) Ltd?
The Face Value of Grauer & Weil (India) Ltd is 1.00.